WILLIAM C MARTIN

CIK 1205885 · Chief Strategy Officer · last filed 2026-08-19

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$109.22M

Companies

14

Total Filings

110

Lifetime Open-Market Net

$101.67M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
UEIC 10%+ Owner 1,301,051 $4.26 $5.55M -$1.37M 1 2026-08-19
IMMR Chief Strategy Officer 3,816,152 $7.79 $29.73M -$8.41M 44 2026-08-04
BNED Director 181,738 $12.54 $2.28M $7.85M 6 2026-07-08
GULFMARK OFFSHORE INC (GLF.WS) Delisted Director 54 -$316.7K 2 2017-12-26
INTERMOLECULAR INC (IMI) Delisted 10%+ Owner 14,527,257 $8.05M 6 2016-12-19
CAS 10%+ Owner 0 $25.99 $0 $16.44M 4 2016-11-07
GULFMARK OFFSHORE INC (GLF) Delisted Director 3,550,306 $387.1K 1 2016-01-04
MRV COMMUNICATIONS INC (MRVC) Delisted 10%+ Owner 2,136,864 $25.59M 3 2015-06-25
SR 10%+ Owner 865,231 $82.83 $71.66M -$1.91M 4 2015-02-03
VITESSE SEMICONDUCTOR CORP (VTSS) Delisted Director 14,321,127 $47.30M 5 2014-11-07
COMVERGE, INC. (COMV) Delisted 10%+ Owner 1,274,867 $2.98M 1 2012-04-13
DERMA SCIENCES, INC. (DSCI) Delisted 10%+ Owner 825,436 $5.90M 5 2012-03-29
SALARY. COM, INC. (SLRY) Delisted Director 67,519 $595.2K 6 2010-05-05
BANKRATE INC (RATE) Delisted Director 0 $17.32 $0 -$1.43M 8 2009-09-01

Recent Filings · Page 10 of 11

110 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2011-05-10 DERMA SCIENCES, INC. (DSCI) Delisted Buy (P) +138,476 $1.13M EDGAR
2011-03-11 Buy (P) +334,308 $745.5K
2010-10-05 U −1,624,095 -$6.61M
2010-07-27 Buy (P) +87,624 $110.0K
2010-05-24 Buy (P) +20,000 $50.0K
2010-05-05 SALARY. COM, INC. (SLRY) Delisted Grant (A) +20,547 $0 EDGAR
2009-10-27 Buy (P) +143,496 $110.1K
2009-10-19 SALARY. COM, INC. (SLRY) Delisted Grant (A) +4,500 $14.4K EDGAR
2009-09-08 SALARY. COM, INC. (SLRY) Delisted Buy (P) +180,000 $522.0K EDGAR
2009-09-04 SALARY. COM, INC. (SLRY) Delisted Buy (P) +6,800 $19.6K EDGAR
Showing 91100 of 110
Page 10 of 11
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.